Behandlung leichter traumatischer Hirnverletzungen mit hochauflösender transkranieller Gleichstromstimulation (HDtDCS-TBI)
Behandlung verbaler Retrievaldefizite bei leichten traumatischen Hirnverletzungen mit hochauflösender transkranieller Gleichstromstimulation
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in military veteran participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition and concussion history predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Using two treatment arms, the study will examine improvement of verbal retrieval and other cognitive deficits associated with remote traumatic brain injury by comparing (1) 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to presupplementary motor area for 20 minutes over 15 sessions to (2) sham tDCS following the same schedule. Additionally, after completing the initial active or sham treatment and 3-month follow-up testing sessions, selected participants will be invited back for newly assigned treatment conditions, 20 minutes over 15 sessions and will be and re-evaluated at 2- and 3-months follow-up testing sessions.
Veterans with histories of traumatic brain injuries and observed cognitive deficits will be randomly assigned to one of the two treatment arms (and re-assigned for the second round of intervention, as described above). Primary outcome verbal retrieval measures, secondary neuropsychological and electroencephalography (EEG) measures, and prescreening assessments for study concussion history and contraindications for treatment will be collected prior to being assigned to a treatment arm (i.e., baseline).
Primary outcome verbal retrieval measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected after treatment sessions 5, 10, and 15 and two times following treatment competition (i.e., 2-months and 3-months). For participants selected for the second round of intervention, primary outcome verbal memory measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected again after treatment sessions 5, 10, and 15 and two times following competition of the second treatment (i.e., 2-months and 3-months).
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Jill Ritter, BS
- Telefonnummer: 972-883-3161
- E-Mail: neurolab.memory@utdallas.edu
Studieren Sie die Kontaktsicherung
- Name: Tyler Vintila
- Telefonnummer: 972-883-3161
- E-Mail: neurolab.memory@utdallas.edu
Studienorte
-
-
Texas
-
Dallas, Texas, Vereinigte Staaten, 75235
- Rekrutierung
- The University of Texas at Dallas
-
Unterermittler:
- Michael Motes, PhD
-
Kontakt:
- Ashna Adhikari
- Telefonnummer: 972-883-3161
- E-Mail: neurolab.memory@utdallas.edu
-
Kontakt:
- Tyler Vintila
- Telefonnummer: 972-883-3161
- E-Mail: neurolab.memory@utdallas.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria: Participants are to be between the ages of 18-75, have previously served in the US armed services, and have had a traumatic brain injury that has led to a verbal retrieval deficit based on neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate range based on evaluation, including, the Ohio State TBI Identification Method (administered by our research group). You must be fluent in speaking and reading English.
Exclusion Criteria: Exclusion criteria include a history of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, severe traumatic brain injury, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis. Additionally, exclusion criteria include inability to give informed consent; cranial implants or skull defects that affect tDCS administration; and use of medications that interact with or potentially interact with tDCS effects, including, anti-convulsants, amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, rivastigmine, dextromethorphan, D-cycloserine, flunarizine, ropinirole, or citalopram.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Transcranial direct current stimulation
20 minutes of 1 milliamp transcranial direct current stimulation to presupplementary motor area for 15 sessions |
Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.
Andere Namen:
|
|
Schein-Komparator: Sham transcranial direct current stimulation
20 minutes of sham transcranial direct current stimulation to presupplementary motor area for 15 sessions |
Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Controlled Oral Word Association Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Control Word Association Test from baseline to 3-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Controlled Oral Word Association Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Control Word Association Test from baseline to 2-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment in Category Fluency
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Category Fluency from baseline to 3-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment in Category Fluency
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Category Fluency from baseline to 2-months. Metric: Number of Correct Items Generated Benton, L.A., Hamsher, K., & Sivan, A.B., (1994). Multilingual aphasia examination. Iowa City: AJA Associates. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Semantic Object Retrieval Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Semantic Object Retrieval Test from baseline to 3-months. Metric: Number of Correct Retrievals Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Semantic Object Retrieval Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Semantic Object Retrieval Test from baseline to 2-months. Metric: Number of Correct Retrievals Kaplan, E., Goodglass, H., & Weintraub, S., (1983). Boston Naming Test (2nd ed.). Lea & Febiger: Philadelphia. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Boston Naming Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Boston Naming Test from baseline to 3-months. Metric: Number of Correct Names Retrieved Kraut, M.A., Cherry, B., Pitcock, C.B., Anand, R., Li, J. Vestal, L., Henderson, V.W., and Hart, J. Jr. (2007). The Semantic Object Retrieval Test (SORT) in amnestic cognitive impairment. Cogn. Behav. Neurol. 20, 62- 67. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Boston Naming Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Boston Naming Test from baseline to 2-months. Metric: Number of Correct Names Retrieved Kraut, M.A., Cherry, B., Pitcock, C.B., Anand, R., Li, J. Vestal, L., Henderson, V.W., and Hart, J. Jr. (2007). The Semantic Object Retrieval Test (SORT) in amnestic cognitive impairment. Cogn. Behav. Neurol. 20, 62- 67. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on California Verbal Learning Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in California Verbal Learning Test from baseline to 3-months. Metric: Number of Correct Retrievals Delis DC, Kramer JH, Kaplan E, Ober BA. (2017). California verbal learning test (3rd Ed.). Pearson Publishing: San Antonio, TX. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on California Verbal Learning Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in California Verbal Learning Test from baseline to 2-months. Metric: Number of Correct Retrievals Delis DC, Kramer JH, Kaplan E, Ober BA. (2017). California verbal learning test (3rd Ed.). Pearson Publishing: San Antonio, TX. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Trail Making Test (Part A)
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part A) from baseline to 3-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Trail Making Test (Part A)
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part A) from baseline to 2-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Trail Making Test (Part B)
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 3-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Trail Making Test (Part B)
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 2-months. Metric: Time to Solution Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Delis Kaplan Color Word Interference Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Delis Kaplan Color Word Interference Test from baseline to 3-months. Metric: Time to Name Items Delis, D.C., Kaplan, E., & Kramer, J.H., (2001). Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Delis Kaplan Color Word Interference Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Trail Making Test (Part B) from baseline to 2-months. Metric: Time to Name Items Reitan, R.M., (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Motor Skill., 8, 271-276. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Span Forward
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Forward from baseline to 3-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Span Forward
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Forward from baseline to 2-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Span Backward
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Backward from baseline to 3-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Span Backward
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Digit Span Backward from baseline to 2-months. Metric: Memory Span Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Rey-Osterrieth Complex Figure Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change in Rey-Osterrieth Complex Figure Test scores from baseline to 3-months. Metric: Score Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Rey-Osterrieth Complex Figure Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change in Rey-Osterrieth Complex Figure Test scores from baseline to 2-months. Metric: Score Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.]. Archives de Psychologie, 28, 215- 285. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Digit Symbol Substitution Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Digit Symbol Substitution Test from baseline to 3-months. Metric: Number of Items Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Digit Symbol Substitution Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Digit Symbol Substitution Test from baseline to 2-months. Metric: Number of Items Wechsler, D., (2008). Wechsler adult intelligence scale-Fourth Edition (WAIS-IV). San Antonio, TX: NCS Pearson. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 3-months Post-Treatment on the Grooved Pegboard Test
Zeitfenster: Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
Evaluation of treatment group differences in change on the Grooved Pegboard Test from baseline to 3-months. Metric: Completion Time Matthews, C.G., and Klove, H. (1964). Instruction manual for the adult neuropsychology test. Madison. Wis: University of Wisconsin Medical School. |
Outcome measures will be assessed as change over a period of 17 weeks: Change from baseline to 3-month Post-Treatment
|
|
Treatment group differences in change from Baseline to 2-months Post-Treatment on the Grooved Pegboard Test
Zeitfenster: Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Evaluation of treatment group differences in change on the Grooved Pegboard Test from baseline to 2-months. Metric: Completion Time Matthews, C.G., and Klove, H. (1964). Instruction manual for the adult neuropsychology test. Madison. Wis: University of Wisconsin Medical School. |
Outcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: John Hart, MD, The University of Texas at Dallas
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des Gehirns
- Erkrankungen des zentralen Nervensystems
- Erkrankungen des Nervensystems
- Wunden und Verletzungen
- Kraniozerebrales Trauma
- Trauma, Nervensystem
- Hirnverletzungen
- Hirnverletzungen, traumatisch
- Therapeutika
- Verhaltensdisziplinen und Aktivitäten
- Elektrische Stimulationstherapie
- Krampfhafte Therapie
- Psychiatrische somatische Therapien
- Elektroschock
- Psychologische Techniken
- Transkranielle Direktstromstimulation
Andere Studien-ID-Nummern
- UTD-TDCSTBI-21-15
- CDMRP-PT190081 (Andere Kennung: CDMRP)
- W81XWH-20-1-0846 (Andere Zuschuss-/Finanzierungsnummer: DOD-CDMRP-USAMRDC)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .